Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Switching From Dupilumab to Tralokinumab or Janus Kinase Inhibitors in Cases of Ocular and/or Facial Adverse Events in Patients With Atopic Dermatitis: A Multicenter Retrospective Study.
Beyrouti A, Deuze J, Fontas E, Foureau A, Barbarot S, Aubert H, Bernier C, Le Moigne M, Passeron T, Boukari F, Garnier M, Jachiet M, Tetart F, Seneschal J, Toussaint C, Mahé E, Leleu C, Regnault MM, Pasteur J, Nosbaum A, Badaoui A, Fougerousse AC, Pralong P, Viguier M, Droitcourt C, Abasq C, Mallet S, Raison-Peyron N, Staumont-Sallé D, Hubiche T; French Atopic Dermatitis Network (FRADEN) from the Groupe de Recherche sur l’Eczéma Atopique (GREAT) Research Group. Beyrouti A, et al. Among authors: hubiche t. J Allergy Clin Immunol Pract. 2024 Dec 12:S2213-2198(24)01241-8. doi: 10.1016/j.jaip.2024.12.001. Online ahead of print. J Allergy Clin Immunol Pract. 2024. PMID: 39672377
Long-term effects of sirolimus treatment for slow-flow vascular malformations: Real-world evidence from the French observational multicentre SIROLO study.
Maillet C, Boccara O, Mallet S, Bessis D, Labrèze C, Mary-Prey S, Guibaud L, Bisdorff A, Dompmartin A, Mazereeuw-Hautier J, Chiaverini C, Hubiche T, Bonniaud B, Degrugillier-Chopinet C, Bursztejn AC, Aubert H, Severino M, Leducq S, Tardieu M, Joly A, Boulouis G, Le Touze A, Paré A, Tavernier E, Maruani A. Maillet C, et al. Among authors: hubiche t. J Eur Acad Dermatol Venereol. 2024 Nov 25. doi: 10.1111/jdv.20385. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 39584318
Dupilumab in atopic-dermatitis-like eczema associated with inborn errors of immunity: A nationwide study.
Guillemin C, Bellon N, Jachiet M, Barbarot S, Bourrat E, Chiaverini C, Cougoul P, Ebbo M, Herber M, Hubiche T, Mallet S, Tauber M, Béziat V, Castelle M, Du Thanh A, Farhi J, Fieschi C, Fournier B, Gourguechon C, Guiddir T, Lipsker D, Raison-Peyron N, Garcelon N, Cheminant M, Suarez F, Hermine O, Blanche S, Moshous D, Mahlaoui N, Neven B, Bodemer C, Lévy R, Polivka L; Groupe de Recherche de la Société Française de Dermatologie Pédiatrique (GR SFDP); French Atopic Dermatitis Network from the Groupe de Recherche sur l’Eczéma Atopique (GREAT). Guillemin C, et al. Among authors: hubiche t. J Am Acad Dermatol. 2025 Jan;92(1):165-168. doi: 10.1016/j.jaad.2024.09.029. Epub 2024 Sep 27. J Am Acad Dermatol. 2025. PMID: 39343308 No abstract available.
Efficacy and tolerance of dupilumab in patients with moderate-to-severe atopic dermatitis and obesity.
Dupuis J, Tauber M, Mahe E, Jachiet M, Soria A, Tetart F, Puzenat E, Pasteur J, Raison-Peyron N, Giordano-Labadie F, Droitcourt C, Leleu C, Nosbaum A, Aubert H, Moigne MLE, Bernier C, Barbarot S, Ezzedine K, Diaz E, Hubiche T, Faiz S, Azib S, Dezoteux F, Chosidow O, Staumont-Salle D; French Atopic Dermatitis Network from the Group of Research and Study in Atopic Dermatitis (GREAT), the French Society of Dermatology (SFD). Dupuis J, et al. Among authors: hubiche t. J Eur Acad Dermatol Venereol. 2024 Jul 31. doi: 10.1111/jdv.20264. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 39082796 No abstract available.
Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials.
Bissonnette R, Warren RB, Pinter A, Agner T, Gooderham M, Schuttelaar MLA, Crépy MN, Stingeni L, Serra-Baldrich E, Baranowski K, Korn S, Kurvits M, Plohberger U, Strange Vest N, Schliemann S; trial investigators. Bissonnette R, et al. Lancet. 2024 Aug 3;404(10451):461-473. doi: 10.1016/S0140-6736(24)01027-4. Epub 2024 Jul 18. Lancet. 2024. PMID: 39033766 Clinical Trial.
Management of scabies in children under 15 kg and pregnant or breastfeeding women: recommendations supported by the Centre of Evidence of the French Society of Dermatology.
Morand A, Weill A, Miquel J, Chosidow O, Guillot B, Tannous J, de Gentile L, Parant E, Quinet B, Boyer M, Maruani A, Bodak N, Phan A, Izri A, Tosello B, Bretelle F, Elefant E, Boralevi F, Letord C, Hubiche T, Mallet S. Morand A, et al. Among authors: hubiche t. Br J Dermatol. 2024 Nov 18;191(6):1014-1016. doi: 10.1093/bjd/ljae288. Br J Dermatol. 2024. PMID: 39028660 No abstract available.
Multifocal tuberculosis: a phenotype of Mendelian susceptibility to mycobacterial disease.
Gourdan P, Colanic I, Blanc S, Fina A, Baque-Juston M, Solla F, Giordano A, Hubiche T, Rohrlich P, Barlogis V, Bustamante J, Boisson-Dupuis S, Giovannini-Chami L. Gourdan P, et al. Among authors: hubiche t. Arch Dis Child. 2024 Jul 18;109(8):673. doi: 10.1136/archdischild-2024-327026. Arch Dis Child. 2024. PMID: 38740434 No abstract available.
Erythema Migrans Caused by Borrelia spielmanii, France.
Del Giudice P, Freychet F, Kopec L, Fenollar F, Eldin C, Velin M, Hubiche T, Raoult D, Mediannikov O. Del Giudice P, et al. Among authors: hubiche t. Emerg Infect Dis. 2023 Nov;29(11):2366-2369. doi: 10.3201/eid2911.230149. Emerg Infect Dis. 2023. PMID: 37877610 Free PMC article.
99 results